Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
2.670
+0.070 (2.69%)
At close: Apr 2, 2025, 4:00 PM
2.510
-0.160 (-5.99%)
After-hours: Apr 2, 2025, 7:12 PM EDT

Revelation Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
6.511.995.251.274.49
Cash & Short-Term Investments
6.511.995.251.274.49
Cash Growth
-45.80%128.28%312.09%-71.63%-
Prepaid Expenses
0.070.080.070.640.13
Other Current Assets
-0.070.09--
Total Current Assets
6.5712.155.411.914.62
Property, Plant & Equipment
0.060.070.090.13-
Total Assets
6.6212.215.52.044.62
Accounts Payable
0.781.360.550.60.87
Accrued Expenses
1.131.150.991.530.34
Current Portion of Leases
---0.02-
Other Current Liabilities
03.052.91--
Total Current Liabilities
1.915.564.452.141.21
Total Liabilities
1.915.564.452.141.21
Common Stock
00000
Additional Paid-In Capital
45.2132.1126.414.425.54
Retained Earnings
-40.51-25.47-25.35-14.52-2.53
Total Common Equity
4.716.651.05-0.13.01
Shareholders' Equity
4.716.651.05-0.13.41
Total Liabilities & Equity
6.6212.215.52.044.62
Total Debt
---0.02-
Net Cash (Debt)
6.511.995.251.264.49
Net Cash Growth
-45.80%128.28%317.57%-72.00%-
Net Cash Per Share
37.89841.76---
Filing Date Shares Outstanding
0.910.1-0-
Total Common Shares Outstanding
0.520.02---
Working Capital
4.656.580.96-0.233.41
Book Value Per Share
9.02402.06---
Tangible Book Value
4.716.651.05-0.13.01
Tangible Book Value Per Share
9.02402.06---
Machinery
0.150.130.130.13-
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q